Contribution of the genetic status of oxidative metabolism to variability in the plasma concentrations of beta-adrenoceptor blocking agents-Reference-Cited by-同舟云学术

Contribution of the genetic status of oxidative metabolism to variability in the plasma concentrations of beta-adrenoceptor blocking agents

Published:1983 Issue:6 Volume:24 Page:797-799
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Dayer P.,Balant L.,K�pfer A.,Courvoisier F.,Fabre J.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00607090.pdf

Reference27 articles.

1. Alvan G, von Bahr C, Seideman P, Sjöqvist F (1982) High plasma concentrations of ?-receptor blocking drugs and deficient debrisoquine hydroxylation. Lancet 1: 333

2. Bertilsson L, Dengler HJ, Eichelbaum M, Schulz HU (1980) Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquine. Eur J Clin Pharmacol 17: 153?155

3. Dayer P, Kubli A, Kupfer A, Courvoisier F, Balant L, Fabre J (1982a) Defective hydroxylation of bufuralol associated with side-effects of the drug in poor metabolisers. Br J Clin Pharmacol 13: 750?752

4. Dayer P, Balant L, Courvoisier F, Kupfer A, Kubli A, Gorgia A, Fabre J (1982b) The genetic control of bufuralol metabolism in man. Eur J Drug Metab Pharmacokinet 7: 73?77

5. Dengler HJ, Eichelbaum M (1977) Polymorphismen und Defekte des Arzneimittelstoffwechsels als Ursache toxischer Reaktionen. Arzneim Forsch 27: 1836?1844

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in pharmacogenomics of drugs acting on hypertension;Pharmacological Research;2004-04

2. Pharmacogenetics of Antihypertensive Drug Responses;American Journal of PharmacoGenomics;2004

3. Evaluation of Cytochrome P450 Probe Substrates Commonly Used by the Pharmaceutical Industry to Study in Vitro Drug Interactions;Drug Metabolism and Disposition;2002-12-01

4. Antihypertensive pharmacogenetics: getting the right drug into the right patient;Journal of Hypertension;2001-01

5. Impact of P450 genetic polymorphism on the first-pass extraction of cardiovascular and neuroactive drugs;Advanced Drug Delivery Reviews;1997-09-15